Search Results - Tsaur, Igor

Refine Results
  1. 1
    Immunotherapy in prostate cancer: new horizon of hurdles and hopes

    Immunotherapy in prostate cancer: new horizon of hurdles and hopes by Tsaur, Igor, Brandt, Maximilian P., Juengel, Eva, Manceau, Cécile, Ploussard, Guillaume

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Correction to: Immunotherapy in prostate cancer: new horizon of hurdles and hopes

    Correction to: Immunotherapy in prostate cancer: new horizon of hurdles and hopes by Tsaur, Igor, Brandt, Maximilian P., Juengel, Eva, Manceau, Cécile, Ploussard, Guillaume

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Utility of Minimally Invasive Technology for Inguinal Lymph Node Dissection in Penile Cancer

    Utility of Minimally Invasive Technology for Inguinal Lymph Node Dissection in Penile Cancer by Nabavizadeh, Reza, Petrinec, Benjamin, Necchi, Andrea, Tsaur, Igor, Albersen, Maarten, Master, Viraj

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Molecular Mechanisms Related with Oligometastatic Prostate Cancer—Is It Just a Matter of Numbers?

    Molecular Mechanisms Related with Oligometastatic Prostate Cancer—Is It Just a Matter of Numbers? by Surcel, Cristian, Kretschmer, Alexander, Mirvald, Cristian, Sinescu, Ioanel, Heidegger, Isabel, Tsaur, Igor

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Pandemic Spread of COVID-19 Mutant Variants Will Facilitate Next-generation Sequencing Capacities for Personalised Medicine in Urologic Oncology

    Pandemic Spread of COVID-19 Mutant Variants Will Facilitate Next-generation Sequencing Capacities for Personalised Medicine in Urologic Oncology by Borgmann, Hendrik, Höfner, Thomas, Sasca, Daniel, Porubsky, Stefan, Tsaur, Igor, Haferkamp, Axel, Dotzauer, Robert

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Resistance after Chronic Application of the HDAC-Inhibitor Valproic Acid Is Associated with Elevated Akt Activation in Renal Cell Carcinoma In Vivo

    Resistance after Chronic Application of the HDAC-Inhibitor Valproic Acid Is Associated with Elevated Akt Activation in Renal Cell Carcinoma In Vivo by Juengel, Eva, Makarević, Jasmina, Tsaur, Igor, Bartsch, Georg, Nelson, Karen, Haferkamp, Axel, Blaheta, Roman A.

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Olive Mill Wastewater Inhibits Growth and Proliferation of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro by Down-Regulating the Akt/mTOR-Signaling Pathway

    Olive Mill Wastewater Inhibits Growth and Proliferation of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro by Down-Regulating the Akt/mTOR-Signaling Pathway by Rutz, Jochen, Maxeiner, Sebastian, Juengel, Eva, Chun, Felix K.-H., Tsaur, Igor, Blaheta, Roman A.

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Resistance to the mTOR Inhibitor Temsirolimus Alters Adhesion and Migration Behavior of Renal Cell Carcinoma Cells through an Integrin α5– and Integrin β3–Dependent Mechanism()()

    Resistance to the mTOR Inhibitor Temsirolimus Alters Adhesion and Migration Behavior of Renal Cell Carcinoma Cells through an Integrin α5– and Integrin β3–Dependent Mechanism()()... by Juengel, Eva, Makarević, Jasmina, Reiter, Michael, Mani, Jens, Tsaur, Igor, Bartsch, Georg, Haferkamp, Axel, Blaheta, Roman A.

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib

    Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib by Juengel, Eva, Kim, Dana, Makarević, Jasmina, Reiter, Michael, Tsaur, Igor, Bartsch, Georg, Haferkamp, Axel, Blaheta, Roman A

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned

    Advantages and Disadvantages of Bone Protective Agents in Metastatic Prostate Cancer: Lessons Learned by Thomas, Christian, Bartsch, Georg, Walter, Christian, Borgmann, Hendrik, Brandt, Maximilian Peter, Höfner, Thomas, Haferkamp, Axel, Tsaur, Igor

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Application of Dried Human Amnion Graft to Improve Post-Prostatectomy Incontinence and Potency: A Randomized Exploration Study Protocol

    Application of Dried Human Amnion Graft to Improve Post-Prostatectomy Incontinence and Potency: A Randomized Exploration Study Protocol by Barski, Dimitri, Gerullis, Holger, Ecke, Thorsten, Boros, Mihaly, Brune, Jan, Beutner, Ulrich, Tsaur, Igor, Ramon, Albert, Otto, Thomas

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Phase 2 of the Coronavirus Pandemic in Urology: Ramping Up Surgical Caseload and Resident Training while COVID-19 Infections Decrease

    Phase 2 of the Coronavirus Pandemic in Urology: Ramping Up Surgical Caseload and Resident Training while COVID-19 Infections Decrease by Borgmann, Hendrik, Boehm, Katharina, Brandt, Maximilian Peter, Kamal, Mohammed M., Mager, Rene, Höfner, Thomas, Tsaur, Igor, Haferkamp, Axel

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells

    Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells by Makarević, Jasmina, Tawanaie, Nassim, Juengel, Eva, Reiter, Michael, Mani, Jens, Tsaur, Igor, Bartsch, Georg, Haferkamp, Axel, Blaheta, Roman A

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Amygdalin Blocks Bladder Cancer Cell Growth In Vitro by Diminishing Cyclin A and cdk2

    Amygdalin Blocks Bladder Cancer Cell Growth In Vitro by Diminishing Cyclin A and cdk2 by Makarević, Jasmina, Rutz, Jochen, Juengel, Eva, Kaulfuss, Silke, Reiter, Michael, Tsaur, Igor, Bartsch, Georg, Haferkamp, Axel, Blaheta, Roman A.

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Amygdalin Influences Bladder Cancer Cell Adhesion and Invasion In Vitro

    Amygdalin Influences Bladder Cancer Cell Adhesion and Invasion In Vitro by Makarević, Jasmina, Rutz, Jochen, Juengel, Eva, Kaulfuss, Silke, Tsaur, Igor, Nelson, Karen, Pfitzenmaier, Jesco, Haferkamp, Axel, Blaheta, Roman A.

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells

    HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells by Juengel, Eva, Najafi, Ramin, Rutz, Jochen, Maxeiner, Sebastian, Makarevic, Jasmina, Roos, Frederik, Tsaur, Igor, Haferkamp, Axel, Blaheta, Roman A.

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Mechanisms behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In Vitro

    Mechanisms behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In Vitro by Juengel, Eva, Natsheh, Iyad, Najafi, Ramin, Rutz, Jochen, Tsaur, Igor, Haferkamp, Axel, Chun, Felix K.-H., Blaheta, Roman A.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Insulin-Like Growth Factor-1 Influences Prostate Cancer Cell Growth and Invasion through an Integrin α3, α5, αV, and β1 Dependent Mechanism

    Insulin-Like Growth Factor-1 Influences Prostate Cancer Cell Growth and Invasion through an Integrin α3, α5, αV, and β1 Dependent Mechanism by Siech, Carolin, Rutz, Jochen, Maxeiner, Sebastian, Grein, Timothy, Sonnenburg, Marlon, Tsaur, Igor, Chun, Felix K.-H., Blaheta, Roman A.

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    What should be the patient’s preference regarding the choice of hospital in the case of radical cystectomy? Evaluation of early complications after open radical cystectomy in a medium and high volume setting in one hospital

    What should be the patient’s preference regarding the choice of hospital in the case of radical cystectomy? Evaluation of early complications after open radical cystectomy in a med... by Mani, Jens, Vallo, Stefan, Brandt, Maximilian P, Gust, Kilian M, Bartsch, Claudia, Daechert, Johannes, Tsaur, Igor, Bartsch, Georg, Haferkamp, Axel

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Influence of the HDAC Inhibitor Valproic Acid on the Growth and Proliferation of Temsirolimus-Resistant Prostate Cancer Cells In Vitro

    Influence of the HDAC Inhibitor Valproic Acid on the Growth and Proliferation of Temsirolimus-Resistant Prostate Cancer Cells In Vitro by Makarević, Jasmina, Rutz, Jochen, Juengel, Eva, Maxeiner, Sebastian, Tsaur, Igor, Chun, Felix K.-H., Bereiter-Hahn, Jürgen, Blaheta, Roman A.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: